The Prehospital Use of Albuterol Inhalation Treatments

Eric A. Vonderohe, James H. Jones, Roland B. McGrath, Leon H. Bell

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The use of bronch odilators in the prehospital EMS setting is common. This study examined the safety of the administration of 2.5 mg albuterol using a hand-held nebulizer for the treatment of such patients. A total of 55 patients were included. Following treatment, peak expiratory flow rates (PEFR) increased a mean of 27 L/min, ventilatory rate decreased four breaths/min, heart rate decreased slightly, and systolic blood pressure increased 10 mmHg. Five of the 53 patients in whom cardiac rhythm was monitored, had premature ventricular complexes prior to treatment; only one did following therapy. Breath sounds improved in 61 % and were unchanged in 39%. Breathing was reported by the patient as improved in 51 of the 53 (93%) and only one felt worse. Adverse reactions were reported in 15 %, but none were severe. This study shows that albuterol (2.5 mg) administration by hand-held nebulizer is both safe and efficacious in the prehospital setting.

Original languageEnglish (US)
Pages (from-to)327-330
Number of pages4
JournalPrehospital and disaster medicine
Issue number3
StatePublished - Sep 1991
Externally publishedYes

ASJC Scopus subject areas

  • Emergency Medicine
  • Emergency

Fingerprint Dive into the research topics of 'The Prehospital Use of Albuterol Inhalation Treatments'. Together they form a unique fingerprint.

Cite this